InsiderClue
← All stocks

ArriVent BioPharma, Inc.

AVBP Net buying
CIK 0001868279 #2270 in the set updated 18 Sep 2026
Bought (120 mo)
$34.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$12.98M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$12.98M
1 of 1 sales
Net
+$21.02M
+$21.02M against sales at will

By person

5 insiders · 15 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GORDON CARL L
Director
$8.00M (2)
—
+$8.00M
1,513,664
3.07%
$35.37M
—
HEALY JAMES
Director
$8.00M (1)
—
+$8.00M
1,696,752
3.44%
$39.65M
—
ORBIMED ADVISORS LLC entity
Director
$8.00M (2)
—
+$8.00M
1,513,664
3.07%
$35.37M
—
HILLHOUSE INVESTMENT MANAGEMENT, LTD. entity
10% owner
$10.00M (1)
$12.98M (1)
−$2.98M
3,929,117
7.97%
$91.82M
—
LaChapelle Robin
Chief Operating Officer
—
—
—
135,736
0.2753%
$3.17M
+39.9%

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
10 Dec 2025
10% owner
Sell indirect
555,555
$23.37
$12.98M
LaChapelle Robin
11 Jul 2025
Chief Operating Officer
Exercised, kept
6,503
$2.28
$14.83K
LaChapelle Robin
11 Jul 2025
Chief Operating Officer
Exercised, kept
2,600
$2.28
$5.93K
LaChapelle Robin
11 Jul 2025
Chief Operating Officer
Exercised, kept
2,050
$2.28
$4.67K
LaChapelle Robin
19 Sep 2024
Chief Operating Officer
Exercised, kept
12,364
$3.65
$45.13K
LaChapelle Robin
19 Sep 2024
Chief Operating Officer
Exercised, kept
2,471
$2.28
$5.63K
LaChapelle Robin
19 Sep 2024
Chief Operating Officer
Exercised, kept
7,164
$2.28
$16.33K
LaChapelle Robin
19 Sep 2024
Chief Operating Officer
Exercised, kept
2,867
$2.28
$6.54K
LaChapelle Robin
19 Sep 2024
Chief Operating Officer
Exercised, kept
2,700
$6.24
$16.85K
HEALY JAMES
30 Jan 2024
Director
Buy indirect
444,444
$18.00
$8.00M
GORDON CARL L
30 Jan 2024
Director
Buy indirect
222,222
$18.00
$4.00M
GORDON CARL L
30 Jan 2024
Director
Buy indirect
222,222
$18.00
$4.00M
ORBIMED ADVISORS LLC
30 Jan 2024
Director
Buy indirect
222,222
$18.00
$4.00M
ORBIMED ADVISORS LLC
30 Jan 2024
Director
Buy indirect
222,222
$18.00
$4.00M
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
30 Jan 2024
10% owner
Buy indirect
555,555
$18.00
$10.00M

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 10,385,912
History held since 29 Jan 2024